Skin Cancer Screenings: Why Are the Benefits in Question?
Main Article Content
Keywords
melanoma, screening, skin cancer, overdiagnosis
Abstract
Abstract not available.
References
1. Matsumoto M, Wack S, Weinstock MA, et al. Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System. JAMA Dermatol. Published online April 06, 2022. doi:10.1001/jamadermatol.2022.0253
2. Swerlick RA. Melanoma Screening—Intuition and Hope Are Not Enough. JAMA Dermatol. Published online April 6, 2022. doi:10.1001/jamadermatol.2022.0082
3. Kulkarni RP, Yu WY, Leachman SA. To Improve Melanoma Outcomes, Focus on Risk Stratification, Not Overdiagnosis. JAMA Dermatol. Published online April 6, 2022. doi:10.1001/jamadermatol.2022.0097
4. Rigel DS, Friedman RJ, Kopf AW, et al. Importance of complete cutaneous examination for the detection of malignant melanoma. J Am Acad Dermatol 1986;14:857-60.
5. Geller AG, Zi Z, Sober A, et al. The first 15 years of the American Academy of Dermatology Skin Cancer Screening Programs: 1985-1999. (J Am Acad Dermatol 2003;48:34-41.
6. Siegel R, Miller K, Fuchs H, et al. Cancer statistics, 2022. CA CANCER J CLIN 2022;72:7–33
7. Waqas R. Shaikh, Stephen W. Dusza, Martin A. Weinstock, Susan A. Oliveria, Alan C. Geller, Allan C. Halpern, Melanoma Thickness and Survival Trends in the United States, 1989–2009, JNCI: Journal of the National Cancer Institute, Volume 108, Issue 1, January 2016, djv294, https://doi.org/10.1093/jnci/djv294
2. Swerlick RA. Melanoma Screening—Intuition and Hope Are Not Enough. JAMA Dermatol. Published online April 6, 2022. doi:10.1001/jamadermatol.2022.0082
3. Kulkarni RP, Yu WY, Leachman SA. To Improve Melanoma Outcomes, Focus on Risk Stratification, Not Overdiagnosis. JAMA Dermatol. Published online April 6, 2022. doi:10.1001/jamadermatol.2022.0097
4. Rigel DS, Friedman RJ, Kopf AW, et al. Importance of complete cutaneous examination for the detection of malignant melanoma. J Am Acad Dermatol 1986;14:857-60.
5. Geller AG, Zi Z, Sober A, et al. The first 15 years of the American Academy of Dermatology Skin Cancer Screening Programs: 1985-1999. (J Am Acad Dermatol 2003;48:34-41.
6. Siegel R, Miller K, Fuchs H, et al. Cancer statistics, 2022. CA CANCER J CLIN 2022;72:7–33
7. Waqas R. Shaikh, Stephen W. Dusza, Martin A. Weinstock, Susan A. Oliveria, Alan C. Geller, Allan C. Halpern, Melanoma Thickness and Survival Trends in the United States, 1989–2009, JNCI: Journal of the National Cancer Institute, Volume 108, Issue 1, January 2016, djv294, https://doi.org/10.1093/jnci/djv294